Strikingly, Bcl-xL-TM, VAMP-2-TM or Pex13-TM could not inhibit MAVS activity in inducing IFN production following virus infection (Fig. 3c), nor was MAVS aggregation affected (Fig. 3d). This evidence concerns the gene IFNA1 and viral infectious disease.